Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Part of paid clinical trials in Denver, Colorado.

Sponsor
QLT Inc.
Study ID
NCT00007969
Phase
PHASE1/PHASE2
Status
Completed

Conditions

  • Melanoma (Skin)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy may be effective in treating melanoma. PURPOSE: Phase I/II trial to study the effectiveness of photodynamic therapy in treating patients who have stage III or stage IV melanoma.

Key Dates

Start date
Oct 31, 2000
Status verified
Aug 2008

Study Design

Primary purpose
TREATMENT

Locations (6)

FacilityCityStateZIPSite coordinators
University of Colorado Cancer CenterDenverColorado80010-
Mount Sinai Comprehensive Cancer Center at AventuraAventuraFlorida33180-
Mount Sinai Comprehensive Cancer CenterMiami BeachFlorida33140-
Barbara Ann Karmanos Cancer InstituteDetroitMichigan48201-1379-
Missouri Baptist Cancer CenterSt LouisMissouri63131-
University of Pittsburgh Cancer InstitutePittsburghPennsylvania15213-3489-

Find similar trials in Denver, CO

By research site
University of Colorado Cancer Center· Denver, COMount Sinai Comprehensive Cancer Center at Aventura· Aventura, FLMount Sinai Comprehensive Cancer Center· Miami Beach, FLBarbara Ann Karmanos Cancer Institute· Detroit, MIMissouri Baptist Cancer Center· St Louis, MOUniversity of Pittsburgh Cancer Institute· Pittsburgh, PA

Related Studies